47 Rue Adrienne Bolland
Familial, idiopathic and drug-induced cardiovascular diseases are leading causes of mortality worldwide. Therefore, it is of great importance to increase our understanding of underlying pathophysiology mechanisms in order to develop effective treatments. hiPSC-derived cardiomyocytes can be utilized for safety and efficacy drug screening, providing novel possibilities for pre-clinical assessment of compound effects.
Ncyte cardiomyocytes are fully functional hiPSC-derived ventricular-like cardiomyocytes derived using our 3D bioreactor technology, that recapitulate healthy human cardiac biology and function. Their relatively slow beat rate enables pacing for electrophysiological research. They offer a valuable cell model for cardiotoxicity testing, drug screening and target validation, as well as for metabolism studies, calcium-imaging and electrophysiology applications.
Ideal for use in cardiotoxicity testing, drug screening, target validation and induced disease models.
Recapitulates healthy human biology and function.
To ensure comparable performance with every batch
Interested in utilizing this manufacturing process for your iPSC line? Contact us to receive a customized quote.
Thank you for signing up to our newsletter.